Deals Rumor Mill: Teva, Colony Capital, Riverstone Holdings
Teva Pharmaceutical Industries Ltd. has nearly clinched up to $2 billion worth of asset sale agreements to help its $40.5 billion proposed purchase of Allergan PLC's generics business, according to a Friday...To view the full article, register now.
Already a subscriber? Click here to view full article